$IBM

IBM Stock Wavers After-Hours Amid Revenue Miss, Lower 2026 Outlook — AI Demand Remains Strong, Says Company

IBM reported Q2 revenue of $17.16B, missing estimates, with infrastructure sales down 7%. It lowered its 2026 revenue outlook to 4-5% growth. Shares fluctuated after-hours, initially up 3% before edging lower. Adjusted earnings matched expectations at $2.93 per share.

Original reporting
Published Aug 29, 2026, 8:46 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 30, 2026, 1:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$IBM
Bearish
high confidence
Mentioned
$IBM
Relevance
8/10
alphai data visualization · based on stocktwits.com
Decision brief

The 30-second read

$IBMBearishHigh
01

Why it matters

The earnings miss and guidance reduction are likely to trigger short‑term selling pressure, though the company's AI positioning may support longer‑term upside.

02

Market read

IBM's earnings and outlook revision are material for investors and can affect related tech and AI infrastructure stocks.

03

What to watch

IBM's recurring software revenue and mainframe stability could provide a revenue floor not fully reflected in the price.

Relevance 8/10Novelty 8/10Timing: after‑hours

Background

IBM announced Q2 results with a slight revenue beat on a 1% YoY increase but missed consensus, and lowered its full‑year 2026 revenue growth to 4‑5% from >5%.

Company-level read

Ticker impact

$IBMBearishHigh confidence
Context

IBM reported Q2 revenue miss and cut its 2026 sales outlook, prompting after‑hours price movement.

Expected impact

Potential downside of 3‑5% over the next few days as investors reassess growth expectations.

Evidence & confidence

Revenue fell short of estimates and guidance was reduced, a material change for a large‑cap tech company.

Market effects

Softening outlook may weigh on the broader enterprise‑software and infrastructure sector.

U.S. tech stocks could see modest pullback in the near term.

IBM's guidance cut could influence global AI‑infrastructure spending sentiment.

Counterpoint

If AI demand accelerates faster than expected, the guidance cut may be overly cautious, presenting a buying opportunity.

Key entities

  • IBM

    International Business Machines Corp., a U.S. listed technology firm.

  • Arvind Krishna

    IBM Chairman, President and CEO who commented on AI-driven future.

Related articles

$IBMMed

IBM completes acquisition of HRL to advance quantum ecosystem

IBM has completed its acquisition of HRL Laboratories, a research firm specializing in quantum computing and related technologies. HRL's expertise in silicon-spin qubits and quantum sensing is expected to enhance IBM's quantum hardware roadmap, supporting projects like the IBM Quantum Starling, a fault-tolerant quantum computer planned for 2029. Boeing and General Motors, HRL's former owners, will continue to collaborate with IBM and HRL on quantum applications.

$IBMLow

IBM Gets Closer to Fault-Tolerant Quantum Computing with New Cryogenic System - TipRanks.com

IBM announced a milestone in quantum computing, connecting and cooling two cryogenic modules to scale quantum computers. The company aims for a 1,000-qubit system by 2027 and a fault-tolerant quantum computer by 2029. IBM shares are slightly down in pre-market trading after a 1.67% gain on Tuesday, closing at $232.67. Analysts give IBM a Moderate Buy consensus with an average price target of $255.78, suggesting 10% upside.

$IBMMed

IBM: Get Paid To Wait For Growth (NYSE:IBM)

IBM maintains a Buy rating despite a 42% drop in mainframe revenue and a forecast miss. Management expects 4-5% full-year revenue growth, supported by acquisitions and software revenue. IBM offers a 2.8% yield and 31 consecutive annual dividend increases. Future growth depends on the z18 mainframe launch in 2028, with near-term risks including hardware revenue gaps.

$BAMedAI 8/10

Boeing, GM Sell HRL Laboratories to IBM - Safari India

Boeing and General Motors (GM) agreed to sell their joint venture, HRL Laboratories, to IBM. The deal is subject to regulatory approval. HRL develops tech for automotive, aerospace, and defense sectors. Boeing and GM will continue collaborating with IBM on quantum computing and other projects. Financial terms were not disclosed.